Investor
M Ventures
Sarah is an Investor with M Ventures, the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. The fund focuses on investments in Biopharmaceuticals and broader Science & Technology areas (Life Science Tools, Display & Semiconductors, Frontier Tech & Sustainability), and Sarah focuses on investments in the areas of frontier tech, sustainability and semiconductors. Prior to joining M Ventures, she earned her PhD from MIT in chemistry, worked as a business strategy consultant and in startups in the nanotechnology and energy & sustainability sectors.
Disclosure information not submitted.
Thursday, July 14, 2022
1:45pm – 2:30pm